Health Care: Drugs

iBio Inc. (IBIO: AMEX)

$0.465 -0.003 | -0.64%
04/17/14 - 03:59 PM ET
Company Income Statement
Jun 2013 Jun 2012 Jun 2011 Jun 2010
Sales 1.01M 1.28M 520.08K 0.00
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 1.01M 1.28M 520.08K 0.00
Selling, General, and Administrative Expenses 4.24M 5.62M 7.09M 2.07M
Research & Development 3.43M 4.98M 3.08M 2.52M
Operating Income before D & A (EBITDA) -6.67M -9.33M -9.65M -4.59M
Depreciation & Amortization 338.00K 329.71K 376.81K 337.03K
Interest Income 9.00K 11.67K 12.62K 12.73K
Other Income - Net 550.00K 3.70M -2.45M -1.49M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -6.45M -5.94M -12.47M -6.40M
Interest Expense 90.00K 62.85K 50.50K 13.11K
Pre-Tax Income -6.54M -6.01M -12.52M -6.41M
Income Taxes 0.00 0.00 0.00 2.40K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -6.20M -5.68M -12.14M -6.08M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -6.20M -5.68M -12.14M -6.08M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -6.20M -5.68M -12.14M -6.08M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-6.20M -5.68M -12.14M -6.08M
Preferred Dividends
Net Income Available To Common -6.20M -5.68M -12.14M -6.08M
Basic EPS from Continuing Ops. -0.13 -0.14 -0.39 -0.22
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.13 -0.14 -0.39 -0.22
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.13 -0.14 -0.39 -0.22
Basic Normalized Net Income/Share -0.13 -0.14 -0.39 -0.22
EPS fr Continuing Ops. -0.13 -0.14 -0.39 -0.22
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.13 -0.14 -0.39 -0.22
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.13 -0.14 -0.39 -0.22
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.13 -0.14 -0.39 -0.22
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with IBIO

Latest IBIO Headlines from TheStreet

More Financial News for IBIO

Press Releases for IBIO

See All Press Releases

Partner Headlines for IBIO

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter